Adhesion Barrier Market By Type (Synthetic Adhesion Barrier, Natural Adhesion Barrier) , By Application (General/Abdominal Surgeries, Gynecological Surgeries, Cardiovascular Surgeries, Orthopedic Surgeries, Neurological Surgeries, Other Applications) By E

Adhesion Barrier Market By Type (Synthetic Adhesion Barrier, Natural Adhesion Barrier) , By Application (General/Abdominal Surgeries, Gynecological Surgeries, Cardiovascular Surgeries, Orthopedic Surgeries, Neurological Surgeries, Other Applications) By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers) : Global Opportunity Analysis and Industry Forecast, 2024-2033

The adhesion barrier market was valued at $0.7 billion in 2023, and is projected to reach $1.5 billion by 2033, growing at a CAGR of 7.8% from 2024 to 2033.
Adhesion barrier is a medical implant that alleviates the risk of adhesion formation during surgeries. Adhesion is an abnormal connections between tissues or organs that can occur after surgery. Other complications associated with adhesion include bowel obstructions, infertility, and chronic pain, which can arise when tissues stick together while healing. To prevent them from sticking, adhesion barriers create a temporary barrier between the tissues.
The growth of the global adhesion barrier market is driven by alarming rise in the risk of post-surgical adhesions. According to a study, 93% of individuals develop adhesions following one or more abdominal operations. Moreover, increase in awareness among healthcare professionals about the complications associated with adhesions and development of innovative adhesion barrier products notably contribute toward the growth of the global market. Researchers and manufacturers are focusing on the development of adhesion barriers made from bioresorbable materials, which are absorbed by the body gradually, thereby eliminating the need for removal procedures. For instance, Baxter Advanced Surgery, one of the leading providers of healthcare solutions, developed Seprafilm adhesion barrier, which is a sterile, bioresorbable, translucent, and hydrophilic adhesion barrier composed of two anionic polysaccharides, modified sodium hyaluronate and carboxymethylcellulose. This adhesion barrier is capable of significantly reducing the extent, incidence, and severity of adhesions. A randomized, prospective, double-blinded, multicenter clinical study involved 183 patients suffering from ulcerative colitis and familiar polyposis who underwent 2-stage intestinal resection surgery. Among these, 51% of the patients of the Seprafilm Adhesion Barrier group were adhesion-free compared to 6% of control patients post at 8-12 weeks of surgery. Furthermore, increase in reimbursement policies for surgical procedures involving adhesion barriers encourage their use, which boosts the growth of the global market. However, there is no specific adhesion barrier that is widely used to prevent post-surgical adhesions, despite ongoing research, which acts as a key deterrent factor of the market. On the contrary, healthcare professionals are incorporating the use of adhesion barriers into their surgical protocols to minimize the risk of adhesion-related complications, which is expected to drive their demand globally. Moreover, rise in initiatives to spread awareness and establish guidelines regarding the prevention and management of adhesions by medical societies and healthcare organizations is anticipated to offer remunerative opportunities for the expansion of the global market during the forecast period.
The global adhesion barrier market is segmented into type, application, end user, and region. On the basis of type, the market is categorized into synthetic adhesion barrier, and natural adhesion barrier. Depending on application, it is segregated into general/abdominal surgeries, gynecological surgeries, cardiovascular surgeries, orthopedic surgeries, neurological surgeries, and others. By end user, it is fragmented into hospitals, Specialty Clinics, Ambulatory Surgical Centers. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By product type, the synthetic adhesion barrier segment dominated the market, in terms of share in 2023.
Depending on application, the general/abdominal surgeries segment was the major shareholder in 2023.
On the basis of end user, the hospital segment acquired the maximum share in 2023.
North America holds a significant share of the market.
Competitive Landscape
The competitive analysis and profiles of the major players in the global adhesion barrier market include Anika Therapeutics Inc., Baxter International Inc., leader biomedical, Betatech Medical, Fziomed, Inc., Integra LifeSciences Holdings Corporation, Johnson & Johnson, CGBio Inc., Atrium Medical Corporation, and Toray Industry Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, which strengthen their foothold in the competitive market.

Key Market Segments

By Type

Synthetic Adhesion Barrier
Natural Adhesion Barrier

By Application

General/Abdominal Surgeries
Gynecological Surgeries
Cardiovascular Surgeries
Orthopedic Surgeries
Neurological Surgeries
Other Applications

By End User

Hospitals
Specialty Clinics
Ambulatory Surgical Centers

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Anika Therapeutics Inc.
Baxter International Inc.
leader biomedical
Betatech Medical
fziomed, inc.
Integra LifeSciences Holdings Corporation
Johnson & Johnson
CGBio Inc
Atrium Medical Corporation
Toray Industries Inc.